Disseminated tuberculosis infection: a ‘super’ 18F-FDG PET/CT appearance

  • Abdul Jalil Nordin
  • Claudio Rossetti
  • Noraini Abdul Rahim
Open Access
Image of the Month


Tuberculosis Malignant Lesion Standard Uptake Image Interpretation Tuberculosis Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

A 28-year-old immigrant presented with a 2-week history of throbbing headache. Contrast-enhanced computed tomography (CECT) examination showed multiple brain abscesses. He is a known defaulter from miliary tuberculosis treatment. 18F-FDG PET/CT demonstrated multiple visually high metabolic activity lesions disseminated in the brain, thorax, abdomen and pelvis [1]. The maximum standard uptake values (SUVmax) of these lesions were substantially > 3.0 and comparable to the uptake of FDG-avid malignant lesions. These findings demand careful image interpretation implicating false-positive results [2, 3]. Our case illustrates the usefulness of 18F-FDG PET/CT in mapping active tuberculous lesions which can be used for baseline study [4].



This paper was supported by International Atomic Energy Agency and Research University Grant UPM in 2008.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.


  1. 1.
    Zhuang H, Yu JQ, Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am 2005;43:121–34. doi: 10.1016/j.rcl.2004.07.005.PubMedCrossRefGoogle Scholar
  2. 2.
    Hofmeyr A, Lau WF, Slavin MA. Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response. Tuberculosis (Edinb) 2007;87:459–63. doi: 10.1016/ Scholar
  3. 3.
    Metser U, Miller E, Lerman H, Even-Sapir E. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence. AJR Am J Roentgenol 2007;189(5):1203–10. doi: 10.2214/AJR.07.2083.PubMedCrossRefGoogle Scholar
  4. 4.
    Kumar R, Chauhan A, Zhuang H, Alavi A. Assessment of therapy response by fluorine-18 fluorodeoxyglucose PET in infection and inflammation. PET Clin 2006;1:191–8. doi: 10.1016/j.cpet.2006.03.002.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2009

Authors and Affiliations

  • Abdul Jalil Nordin
    • 1
  • Claudio Rossetti
    • 2
  • Noraini Abdul Rahim
    • 3
  1. 1.Nuclear Imaging Unit, Faculty Medicine and Health SciencesUniversity Putra MalaysiaSerdangMalaysia
  2. 2.Department of Advanced Technology (Nuclear Medicine)Ospedale NiguardiaMilanItaly
  3. 3.Radiology DepartmentSerdang HospitalSerdangMalaysia

Personalised recommendations